Bioxcel Therapeutics's total assets for Q2 2025 were $25.79M, a decrease of -33.13% from the previous quarter. BTAI total liabilities were $133.46M for the fiscal quarter, a 3.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.